Abstract
The number of occupants in a space influences the risk of far-field airborne transmission of SARS-CoV-2 because the likelihood of having infectious and susceptible people both correlate with the number of occupants. This paper explores the relationship between occupancy and the probability of infection, and how this affects an individual person and a population of people. Mass-balance and dose-response models determine far-field transmission risks for an individual person and a population of people after sub-dividing a large reference space into 10 identical comparator spaces.
For a single infected person when the per capita ventilation rate is preserved, the viral dose received by an individual person in the comparator space is 10-times higher because the equivalent ventilation rate per infected person is lower.
However, accounting for population dispersion, such as the community prevalence, the probability of an infected person being present and uncertainty in their viral load, shows the probability of transmission increases with occupancy level. Also, far-field transmission is likely to be a rare event that requires a set of Goldilocks conditions that are just right, when mitigation measures have limited effect.
Therefore, resilient buildings should deliver the equivalent ventilation rate required by standards and increase the space volume per person, but also require reductions in the viral loads and the infection rate of the wider population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors acknowledge the Engineering and Physical Sciences Research Council (EP/W002779/1) who financially supported this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
This version of the manuscript has been revised to add a few more additional references and amend some typographical errors to improve the readability prior to submission for review
1 [add SM link]
2 a buffer solution resists a change in its pH when a small quantity of acid or alkali is added to it
3 [add SM link]1
4 [add SM link]1
Data Availability
All data produced in the present work are contained in the manuscript and Supplemental Materials
Nomenclature
- Ī
- mean number of infected people present
- mean dose in a space where one infected personis present
- Ī
- mean number of infected people in a space that contains a potential transmission event
- mean individual probability of infection occurring in a scenario
- mean individual infection risk that occurs in all potential transmission scenarios
- ϕ
- total removal rate (s−1)
- C
- community infections rate (%)
- D
- dose (viable virions)
- G
- emission rate of RNA copies (RNA copies s−1)
- I
- number of infected people
- K
- fraction of aerosol particles absorbed by respiratory tract
- k
- reciprocal of the probability that a single pathogen initiates an infection
- L
- viral load (RNA copies per ml of respiratory fluid)
- N
- number of occupants
- Ns
- number of susceptible people exposed
- Ns(I)
- number of susceptible people exposed in spaces that contain I infected people
- Nt
- number of transmissions in the entire population
- Nt(I)
- number of transmissions that occur in spaces that contain I infected people
- Npop
- population size
- P (0 < I < N)
- probability of a space containing a potential transmission
- P (I)
- probability of I infected people present
- P (L)
- probability of a viral load
- P (R)
- individual probability of infection
- P (S)
- probability of a person being both susceptible and exposed to the virus
- qsus
- susceptible person respiratory rate (m3 s−1)
- T
- exposure period (s)
- V
- space volume (m3)
- v
- viable fraction
